Abstract:Adipogenesis is tightly regulated by various factors, including genes and microRNAs. Excessive fat deposition is the key feature of obesity, which is a low-grade chronic inflammatory disease. Follistatin-like 1 (FSTL1) has been reported to be an important mediator involved in various inflammatory diseases. However, the underlying mechanism of FSTL1 in preadipocyte differentiation and inflammatory response is still unclear. The current study was designed to explore the biological function and potential mechanism of FSTL1 in mouse subcutaneous preadipocyte differentiation. We found that FSTL1 was highly expressed in the early stage of differentiation and subsequently decreased sharply, suggesting that FSTL1 played a possible role in adipogenesis. Meanwhile, the gain-and loss-of- function assays showed that FSTL1 was not only involved in the inflammatory response by inducing the expression of pro-inflammatory factors IL-1 beta and CCL2 but also significantly attenuated preadipocyte differentiation, as evidenced by the reduction of lipid accumulation and the levels of adipogenic genes, including PPAR. and FABP4. In addition, the target gene prediction and luciferase reporter assay validated that miR-125a- 3p targeted the 3' UTR region of FSTL1. These results demonstrated that miR-125a- 3p negatively regulated the expression of FSTL1 at the mRNA and protein levels. Furthermore, overexpressing miR-125a3p in preadipocytes dramatically accelerated adipogenic differentiation and downregulated the levels of IL-1 beta and CCL2, which were in accordance with the knockdown of FSTL1. On the contrary, treatment with miR-125a- 3p inhibitors attenuated adipogenesis but induced the expression of inflammatory genes. In summary, this study suggests a positive function of FSTL1 in adipocyte-induced inflammation and negatively regulates preadipocyte differentiation. Further studies demonstrated that miR-125a- 3p could reverse the effect by targeting FSTL1, which might provide a better understanding of treating obesity-related inflammatory diseases.

MicroRNA‐139‐5p Suppresses 3T3‐L1 Preadipocyte Differentiation Through Notch and IRS1/PI3K/Akt Insulin Signaling Pathways

MicroRNA-24 promotes 3T3-L1 adipocyte differentiation by directly targeting the MAPK7 signaling.

MiR-196b-3p and Mir-450B-3p Are Key Regulators of Adipogenesis in Porcine Intramuscular and Subcutaneous Adipocytes.

Mir-10B-5p Regulates 3T3-L1 Cells Differentiation by Targeting Apol6.

MicroRNA‐344 Inhibits 3T3‐L1 Cell Differentiation Via Targeting GSK3β of Wnt/β‐catenin Signaling Pathway

MicroRNA-125a-5p Mediates 3T3-L1 Preadipocyte Proliferation and Differentiation

MicroRNA-204-5p Regulates 3T3-L1 Preadipocyte Proliferation, Apoptosis and Differentiation

Mature Mir-183, Negatively Regulated by Transcription Factor GATA3, Promotes 3T3-L1 Adipogenesis Through Inhibition of the Canonical Wnt/β-catenin Signaling Pathway by Targeting LRP6

MicroRNA-215 Impairs Adipocyte Differentiation and Co-Represses FNDC3B and CTNNBIP1

MiR‐25 Suppresses 3T3‐L1 Adipogenesis by Directly Targeting KLF4 and C/EBPα

MiR-144-3p Targets FoxO1 to Reduce Its Regulation of Adiponectin and Promote Adipogenesis

MicroRNA-143a-3p Modulates Preadipocyte Proliferation and Differentiation by Targeting MAPK7

miR-125a-3p regulates the expression of FSTL1, a pro-inflammatory factor, during adipogenic differentiation, and inhibits adipogenesis in mice

MiR-146a-5p, Targeting ErbB4, Promotes 3T3-L1 Preadipocyte Differentiation Through the ERK1/2/PPAR-γ Signaling Pathway

Mir-152 Regulates 3T3-L1 Preadipocyte Proliferation and Differentiation

miR-135 a-5 p inhibits 3 T 3L 1 adipogenesis through activation of canonical Wnt / b-catenin signaling

miR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2

Mir-144-3p Promotes Adipogenesis Through Releasing C/EBPα from Klf3 and CtBP2

Overexpression of Microrna-9 Inhibits 3T3-L1 Cell Adipogenesis by Targeting PNPLA3 Via Activation of AMPK.

Mir-135A-5p Inhibits 3T3-L1 Adipogenesis Through Activation of Canonical Wnt/β-catenin Signaling.

MiR‐540 As a Novel Adipogenic Inhibitor Impairs Adipogenesis Via Suppression of PPARγ